Tang Haiqiong, Peng Qiu, Oyang Linda, Tan Shiming, Jiang Xianjie, Ren Zongyao, Xu Xuemeng, Shen Mengzhou, Li Haofan, Peng Mingjing, Xia Longzheng, Yang Wenjuan, Li Shizhen, Wang Jiewen, Han Yaqian, Wu Nayiyuan, Tang Yanyan, Lin Jinguan, Liao Qianjin, Zhou Yujuan
The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism Changsha, Hunan 410013, China.
University of South China, Hengyang, Hunan 421001, China.
Genes Dis. 2025 Jan 20;12(5):101536. doi: 10.1016/j.gendis.2025.101536. eCollection 2025 Sep.
The processes of tumorigenesis and development are intricate, involving numerous genes and molecular pathways. Fusion genes, direct products of abnormal chromosomal rearrangements, are key factors in the formation of many types of tumors. In recent years, the advent of sequencing technology and bioinformatics has led to the discovery of more fusion genes associated with specific types of tumors. The objective of this review is to undertake a comprehensive examination of the discovery and functional mechanisms of fusion genes present in a range of cancers. This will include an analysis of their impact on the biological properties of tumor cells. This review will examine the most prevalent types of fusion genes observed in representative tumor types, including hematological tumors, lung cancer, soft tissue sarcomas, thyroid cancer, and prostate cancer. We provide an overview of the roles and clinical significance of fusion genes, as well as a summarization of the therapeutic strategies for fusion genes, including the application of targeted drugs and related studies. This review presents a comprehensive analysis of the function of fusion genes in the development and treatment of tumors, providing guidance and insights for future research and clinical practice.
肿瘤发生和发展的过程错综复杂,涉及众多基因和分子通路。融合基因是染色体异常重排的直接产物,是多种肿瘤形成的关键因素。近年来,测序技术和生物信息学的出现促使人们发现了更多与特定类型肿瘤相关的融合基因。本综述的目的是全面考察一系列癌症中融合基因的发现及其功能机制,这将包括分析它们对肿瘤细胞生物学特性的影响。本综述将研究在代表性肿瘤类型中观察到的最常见的融合基因类型,包括血液系统肿瘤、肺癌、软组织肉瘤、甲状腺癌和前列腺癌。我们概述了融合基因的作用和临床意义,以及融合基因的治疗策略总结,包括靶向药物的应用及相关研究。本综述对融合基因在肿瘤发生发展及治疗中的作用进行了全面分析,为未来的研究和临床实践提供指导和见解。